EFFICACY AND SAFETY OF PD-1 INHIBITORS MONOTHERAPY FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

Background Immunotherapy represented by programmed death protein-1 (PD-1) inhibitors has gradually become the standard treatment of advanced non-small cell lung cancer (NSCLC) in recent years, changing the treatment landscape of advanced NSCLC.However, most PD-1-related studies excluded patients with NSCLC more than 70 or 75 years, resulting Handle

Railway transport is facing a growing liquidity problem.The major problem in small systems is the detention of wagonsat marshalling yards, which prolongs the time Drop Foot Support of freight travel.To avoid this problem it is of great importance to search for parametersthat would enable creation of a model of technologythat would provide shorter w